Who Champions the Patient? Indian Medical Board Defers Heated Patient Appeals Dispute to Health Ministry

NEW DELHI — In a major development altering the landscape of medical accountability in India, the Ethics and Medical Registration Board (EMRB) of the National Medical Commission (NMC) has officially deferred a long-standing dispute regarding patient appeal rights to the Ministry of Health and Family Welfare. The decision, formalized via an office memorandum, seeks an official, legally binding interpretation of the National Medical Commission Act, 2019.

This administrative shift follows over five years of systemic rejections, during which the apex medical regulator blocked hundreds of patient appeals against state-level decisions involving medical negligence or professional misconduct. The move has re-ignited an intense national debate among consumer rights advocates, legal experts, and healthcare organizations regarding systemic transparency and the basic rights of those navigating medical grievances.

The Core Dispute: A Question of One Missing Word

The administrative stalemate centers on a granular but highly consequential reading of Section 30(3) of the NMC Act, 2019. The statutory text states:

“A medical practitioner or professional who is aggrieved by any action taken by a State Medical Council under sub-section (2) may prefer an appeal to the Ethics and Medical Registration Board (EMRB) against such action.”

In October 2021, the EMRB interpreted this clause as a restrictive boundary, effectively ruling that only registered medical professionals possessed the right to appeal decisions made by State Medical Councils (SMCs).

“Even though nothing in Section 30(3) expressly bars patients from filing appeals, the NMC decided in October 2021 that only appeals from doctors would be allowed,” explains Dr. KV Babu, an ophthalmologist and Right to Information (RTI) activist based in Kannur, Kerala. Dr. Babu, who has legally challenged the board’s stance through successive RTI inquiries since 2022, emphasizes that the regulator unilaterally inserted a restrictive framework. “The word ‘only’ was inserted by the NMC. It simply does not exist in the actual text of Section 30(3).”

Statistical Disparity: 100% Acceptance vs. 100% Rejection

Official data obtained through multiple RTI queries highlights a stark disparity in how the regulatory body handled incoming petitions between September 2020 and January 2026.

Over this five-year window, the EMRB dismissed an average of one patient appeal every single week. In the calendar year 2021 alone, at least 65 patient appeals were summarily thrown out on the grounds of “non-maintainability”—meaning the board deemed that non-doctors lacked the legal standing to even request a review. Meanwhile, every single one of the 185 appeals filed by doctors seeking relief from SMC disciplinary actions was successfully admitted for review.

Historical Precedent and Broken Continuity

The current regulatory freeze stands in direct contrast to prior medical governance frameworks. Under the previous Indian Medical Council (Professional Conduct, Etiquette, and Ethics) Regulations, 2002, the right of a patient to appeal was explicitly protected. Specifically, Clause 8.8—which was implemented following a landmark 2003 Supreme Court order—stated that any person aggrieved by an SMC decision regarding a complaint against a physician had a 60-day window to appeal to the central Medical Council of India (MCI).

When the NMC Act replaced the MCI in 2020, the transition laws mandated that all rules and regulations established under the old 1956 Act would remain active and operational until new standards were formally specified. Despite this legal bridge, the EMRB asserted that Clause 8.8 was completely abolished on September 25, 2020.

“My repeated argument is that patients have the right to appeal against decisions of state medical councils under the ethics regulations of 2002, which have been in force all through,” says Dr. Babu. He notes that because the original ethics code has not been formally replaced, the absolute denial of patient voices bypasses established legal precedents.

Internal Shifts and Policy Gridlock

The gridlock is further complicated by internal policy reversals within the NMC that were never translated into executive action. Minutes from the NMC’s 14th general meeting in May 2024, which were ratified during its 16th meeting in December 2024, explicitly note: “NMC has agreed that all appeals received by EMRB will be entertained.”

NMC official Dr. Srinivas confirmed that comprehensive stakeholder consultations had previously led to a consensus. “It was decided by the Commission that just because a specific line stating ‘patients can appeal’ is missing from the NMC Act, that does not construe they cannot appeal,” Dr. Srinivas stated, noting that the commission intended to grant patients reciprocal appeal rights if they were unsatisfied with state-level outcomes.

Despite these high-level resolutions, the EMRB division continued its practice of turning away non-doctor appellants, highlighting a deep operational divide between the commission’s internal policy decisions and the board’s execution.

Public Health Implications and Legislative Friction

For health-conscious consumers and healthcare professionals alike, this ongoing dispute limits the efficiency of medical grievance redressal systems in India. Legal experts note that a transparent, two-way appeal mechanism is crucial for maintaining public trust in institutional medicine. When patients are structurally blocked from seeking higher administrative reviews, it can drive grievances away from medical boards and directly into an already overburdened consumer court system.

On the legislative front, the Union Health Ministry has long been aware of this regulatory gap. The draft National Medical Commission (Amendment) Bill, which was made public in December 2022 and approved internally in 2023, features an explicit provision designed to allow patients, relatives, or complainants to prefer an appeal to the EMRB in matters concerning medical negligence. However, that bill remains stalled in legislative limbo.

The Counterargument from Regulators

Defenders of the ministry’s cautious approach point out that administrative bodies must strictly adhere to statutory boundaries. From a literalist legal perspective, expanding an appeal process to include a new class of appellants requires formal amendments passed by Parliament, rather than basic regulatory interpretation. Furthermore, certain State Medical Council Acts feature alternative provisions allowing individuals to file appeals directly through state government mechanisms, creating a parallel framework that complicates central intervention.

What Lies Ahead

With the EMRB’s issuance of the latest office memorandum, the responsibility now sits squarely with the Union Health Ministry. The ministry’s upcoming legal determination will need to address three key issues:

• Whether the consumer-protective protections of Clause 8.8 from the 2002 regulations survived the 2020 institutional transition.

• Whether the EMRB can legally interpret Section 30(3) symmetrically to include patients without explicit statutory text.

• Whether the long-delayed 2022 Amendment Bill must be fast-tracked through Parliament to resolve the crisis.

Until a formal clarification is delivered, the gates of the apex medical regulator remain firmly closed to patient-side appeals, leaving hundreds of families across India waiting for an accessible path to accountability.

References

• https://medicaldialogues.in/health-news/nmc/appeals-against-state-medical-council-decisions-emrb-refers-nmc-act-interpretation-to-health-ministry-172360

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.